PV Bulletin

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

W. L. Gore & Associates, Inc. has initiated a voluntary recall of 424 Gore Viabahn endoprostheses due to quality control issues causing potential safety risks.

Primary source: Téléchargez le courrier de la société Gore (07/09/2026)

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

Urgency: HighConfidence: high

What changed

A voluntary recall has been initiated affecting 424 devices manufactured under faulty conditions, limiting their operational integrity.

Why it matters

The recall is crucial to prevent potential severe patient injuries during procedures, including distal tip separation and related complications that could require additional surgical interventions.

Action needed

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Relevant for
QPPVMedical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 7, 2026

Full briefing

Practical implication

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

W. L. Gore & Associates, Inc. has announced a voluntary recall of 424 Gore Viabahn endoprostheses with bioactive heparin coating after discovering that some devices were manufactured outside validated equipment ranges, resulting in the potential for distal tip separation. This could lead to serious complications during medical procedures, although no serious adverse events have been reported as of August 18, 2026.

What changed: A voluntary recall has been initiated affecting 424 devices manufactured under faulty conditions, limiting their operational integrity.

Why it matters: The recall is crucial to prevent potential severe patient injuries during procedures, including distal tip separation and related complications that could require additional surgical interventions.

Practical implication: Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

View original source

  • Source: ANSM (France) - Safety information feed
  • Published at source: 2026-09-07T00:00:00.000Z
  • Discovered by monitor: 2026-09-07T21:36:51.069Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of StrykeFlow PS Irrigation/Suction Devices and AHTO Tubing – Stryker

Urgency: High

Clinics and healthcare facilities are required to verify their inventory immediately and isolate any affected units to prevent accidental use.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward